Connect with us

Finance

COVID-19: CBN to Support Development of Vaccine

Published

on

Godwin Emefile
  • COVID-19: CBN to Support Development of Vaccine

The Central Bank of Nigeria on Tuesday said it will support Nigerian scientists, researchers, and firms to develop Nigerian Vaccine for COVID-19.

In a series of tweets via its official Twitter page, the apex bank challenges Nigerian scientists across the world to develop a Nigerian vaccine to combat and contain the deadly virus.

The central bank said it has developed a framework for grants and long-term facilities for biotechnology firms, researchers and science institutions to develop a vaccine.

The tweets read “the CBN develops a framework for grants and long-term facilities to researchers, science institutions and biotechnology firms to develop Nigerian Vaccine for Corona Virus.

Governor of the Central Bank of Nigeria, Godwin Emefiele, says “the CBN will support development of vaccine ONCE validated by the Health Authorities

He, therefore “challenged Nigerian Scientists across the world to develop a Nigerian vaccine to check coronavirus.”

CEO/Founder Investors King Ltd, a foreign exchange research analyst, contributing author on New York-based Talk Markets and Investing.com, with over a decade experience in the global financial markets.

Finance

FG to Manage Revenue of NNPC, FIRS, Others as COVID-19 Plunges Revenue

Published

on

Zainab Ahmed

FG Takes Control of NNPC, Customs, FIRS, Others Revenue Management

Federal Government on Tuesday said it will henceforth take charge of 10 Government-Owned Enterprises (GOE) to better manage and boost its resources amid dwindling revenues.

Minister of Finance, Budget and National Planning, Mrs Zainab Ahmed, disclosed this at the opening of a three-day orientation programme for 50 directors of revenue that are to be posted to various GOEs in Abuja.

She listed the 10 GOE as the Nigerian National Petroleum Corporation (NNPC), Nigerian Ports Authority (NPA), Nigeria Maritime Administration and Safety Agency (NIMASA), Federal Inland Revenue Service (FIRS) and Nigeria Customs Service (NSS).

Others include Corporate Affairs Commission (CAC), Department of Petroleum Resources (DPR), Nigerian Communications Commission (NCC) Federal Airports Authority of Nigeria (FAAN) and Nigeria Shippers’ Council (NSC).

This, she said was in line with Presidential approval conveyed via SGF’s circular reference SGF.50/S.3/C.9/24 dated 16th October 2018 on the approved Revenue Performance Management Framework for Government Owned Enterprises (FGOEs).

According to her, “government is increasingly concerned with the dwindling profile of Revenue and this trend has to be quickly arrested particularly with Key revenue generating agencies of the Government.”

“It is my considered opinion that the presence of Directors of Revenue at the FGOEs will ensure strict adherence to extant rules and regulations in the areas of compliance to approved budget and due process mechanism in procurement and payments.”

“The Directors of Revenue, in the course of the discharge of their functions, shall be involved in the revenue operations of the FGOEs, have a better understanding of business processes and operations of the FGOEs and cause improved transparency and accountability in revenue reporting by the FGOEs.”

“In addition, they are expected to seek opportunities and avenues for revenue improvements which are the ultimate aim of the Government. I am pleased to inform you that the discharge of these duties will be aided with the deployment of Information Technology.”

“The Integrated Revenue Monitoring System is being put in place to help the monitoring of the revenues of the FGOEs online real-time and to ensure its improved transparency and accountability.”

“This programme is designed as an orientation to the officers that will be posted as Directors of Revenues and is hoped that this will help them to discharge their duties effectively and efficiently and most importantly in utmost good faith.”

Continue Reading

Finance

CBN Reduced Interest Rate by 100 Basis Points to 11.5%

Published

on

cbn

CBN-Led Monetary Policy Reduces Benchmark Interest Rate to 11.5%

The Central Bank of Nigeria led Monetary Policy Committee (MPC) on Tuesday lowered the official interest rate by 100 basis points from 12.5 percent to 11.5 percent to stimulate growth and ease access to funds for businesses in the real sector.

The MPC had refused to reduce the interest rate from 12.5 percent despite the COVID-19 negative impacts on businesses and the economy at large. However, the change in tone may not be unconnected to the severity of Nigeria’s economic situation following a series of negative economic data from the National Bureau of Statistics (NBS).

Nigeria’s economy contracted by 6.10 percent in the second quarter while the unemployment rate rose to 27.1 percent or 21.8 million people and inflation hovering above 13 percent. This was after the apex bank adjusted the nation’s exchange rate twice to accommodate falling foreign reserves and discourage capital flight by most foreigners looking to exit the economy as uncertainties jumped to a record-high.

Still, with fast falling consumer spending amid huge unemployment numbers, the new monetary policy rate may not be effective as businesses need demand to thrive, a situation Nigeria may not experience in the near-term given recent increases in electricity tariff, petrol pump price and Value Added Tax.

Again, while Nigerians are being taxed to death and forced to pay more even with the decline in the value of the Naira, the same people are expected to patronise and sustain businesses without jobs.

The committee retains Cash Reserve Ratio at 27.5 percent while the liquidity ratio stood at 30 percent and the asymmetric corridor from +200/-500 around the MPR.

Continue Reading

Finance

Healthcare Startups Raised $111.4bn in Total Funding, a 34% Jump Year-on-Year

Published

on

Startups in the Healthcare Sector Raises $111.4bn in Funding

The coronavirus pandemic put enormous pressure on the healthcare industry, forcing pharmaceutical giants and institutions to roll out clinical trials for a COVID-19 vaccine at breakneck speed. But behind the COVID-19 outbreak as the main healthcare issue in 2020, large health systems and venture capital firms continued investing millions in startups whose products could bring critical healthcare delivery innovation.

According to data presented by Buy Shares, UK, the total amount of funds healthcare startups raised over time hit $111.4bn in September, a 34% jump year-on-year.

Total Funding Amount Surged by 162% in Three Years

In 2015, healthcare startups worldwide raised $5.4bn in funding rounds, with the cumulative value of investments reaching $24.4bn that year, revealed the CrunchBase data. During the next two years, this figure surged by more than 68%, reaching $45.5bn in the fourth quarter of 2017.

Statistics show that 2018 delivered a $19.2bn of investments into healthcare startups, while the cumulative funding value rose to $64.7bn. In 2019, the total value of raised funds jumped by $24.7bn to $89.4bn, the most significant increase year-on-year.

The Crunchbase data revealed the first quarter of 2020 delivered $7.1bn worth investments into healthcare startups, a 51% increase year-on-year. Between April and June, the cumulative value of funding rose to $103.7bn and continued growing. Statistics show the total funding amount healthcare startups raised over time surged by 162% in the last three years.

Analyzed by geography, North America represents the leading region with $72.4bn of investments in healthcare startups. The US companies raised more than 97% of that amount, with California and San Francisco as the leading hubs. Asian startups hit $25.5bn in total funding, ranking as the second-leading region globally. European healthcare startups follow with $12.8bn worth funding rounds.

Three Largest Funding Rounds in 2020 Worth Over $2bn

The CrunchBase data also revealed the three largest healthcare startup funding rounds this year hit over $2bn value.

Last month, JD Health, the healthcare unit of Chinese e-commerce giant JD.com, raised more than $830 million from Hillhouse Capital in Series B funding, the largest investment in 2020. The company announced it would use this capital to further strengthen its pharmacy supply chain capabilities and explore additional healthcare services opportunities in the broader healthcare sector.

In July, Seattle-based biotech startup Sana Biotechnology raised $700 million in initial financing that will be used to advance the company’s discovery and development programs that deliver engineered cells as a treatment for different types of diseases.

Statistics show that Lyell Immunopharma`s $493 million worth Series C funding round represents the third-largest healthcare startup investment in 2020. Last year, the San Francisco-based company joined forces with GlaxoSmithKline plc to develop new technologies to improve cell therapies for cancer patients.

Continue Reading

Trending